166 related articles for article (PubMed ID: 15068401)
1. Patterns of lamotrigine use in daily clinical practice during the first 5 years after introduction in the Netherlands.
Knoester PD; Belitser SV; Deckers CL; Keyser A; Renier WO; Egberts AC; Hekster YA
J Clin Pharm Ther; 2004 Apr; 29(2):131-8. PubMed ID: 15068401
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
3. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
LeLorier J; Duh MS; Paradis PE; Lefebvre P; Weiner J; Manjunath R; Sheehy O
Neurology; 2008 May; 70(22 Pt 2):2179-86. PubMed ID: 18505997
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study.
Knoester PD; Keyser A; Renier WO; Egberts AC; Hekster YA; Deckers CL
Epilepsy Res; 2005 Jun; 65(1-2):93-100. PubMed ID: 16023833
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of a cohort of lamotrigine users through community pharmacists: differences between patients who gave informed consent and those who did not.
Knoester PD; Belitser SV; Deckers CL; Keyser A; Renier WO; Egberts AC; Hekster YA
Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):107-12. PubMed ID: 15386696
[TBL] [Abstract][Full Text] [Related]
6. Diffusion of the new antiepileptic drug lamotrigine in Dutch clinical practice.
Knoester PD; Belitser SV; Deckers CL; Keyser A; Renier WO; Egberts AC; Hekster YA
Eur J Clin Pharmacol; 2004 Dec; 60(10):751-8. PubMed ID: 15619137
[TBL] [Abstract][Full Text] [Related]
7. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population.
Landmark CJ; Fossmark H; Larsson PG; Rytter E; Johannessen SI
Epilepsy Res; 2011 Jun; 95(1-2):51-9. PubMed ID: 21435840
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
Sunder TR; McKee JR; Hammer AE; Vuongc A
Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of combination drug therapy in refractory epilepsy.
Poolos NP; Warner LN; Humphreys SZ; Williams S
Neurology; 2012 Jan; 78(1):62-8. PubMed ID: 22170887
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
[TBL] [Abstract][Full Text] [Related]
11. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy.
Kluger G; Berz K; Holthausen H
Eur J Paediatr Neurol; 2001; 5(1):37-40. PubMed ID: 11277363
[TBL] [Abstract][Full Text] [Related]
12. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
[TBL] [Abstract][Full Text] [Related]
13. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy.
Camfield P; Camfield C
Neurology; 2005 Mar; 64(6):973-5. PubMed ID: 15781810
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of add-on lamotrigine therapy in clinical practice.
Knoester PD; Boendermaker AJ; Egberts AC; Hekster YA; Keyser A; Severens JL; Renier WO; Deckers CL
Epilepsy Res; 2005 Dec; 67(3):143-51. PubMed ID: 16288850
[TBL] [Abstract][Full Text] [Related]
15. Incidence and determinants of migraine prophylactic medication in the Netherlands.
Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC
Eur J Clin Pharmacol; 2002 May; 58(2):149-55. PubMed ID: 12012149
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands.
van de Vrie-Hoekstra NW; de Vries TW; van den Berg PB; Brouwer OF; de Jong-van den Berg LT
Eur J Clin Pharmacol; 2008 Oct; 64(10):1013-20. PubMed ID: 18618103
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
[TBL] [Abstract][Full Text] [Related]
18. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
Hwang H; Kim H; Kim SH; Kim SH; Lim BC; Chae JH; Choi JE; Kim KJ; Hwang YS
Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
[TBL] [Abstract][Full Text] [Related]
19. The clinical efficacy of lamotrigine as an antiepileptic drug.
Pellock JM
Neurology; 1994 Nov; 44(11 Suppl 8):S29-35. PubMed ID: 7970004
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic drugs in Australia: 2002-2007.
Hollingworth SA; Eadie MJ
Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):82-9. PubMed ID: 19802824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
